Connecting to SEC EDGAR… PricingSign in
← All filings
aTYR PHARMA INCATYR · Nov 6, 4:08 PM ET

aTyr Files Prospectus Supplement for Up to $79,994,251 Common Stock Sales

aTyr Pharma filed a prospectus supplement allowing it to sell up to $79,994,251 of common stock through an open market sale agreement with Jefferies LLC.

AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.